SFZN.SW Siegfried Holding AG (SIX) -4.50% to CHF87.10 on 17 Feb 2026: earnings in focus

Siegfried Holding AG (SFZN.SW) shares slipped -4.50% intraday to CHF87.10 on 17 Feb 2026 as traders position ahead of the company’s earnings call on 20 Feb 2026. The drop follows an intraday range between CHF86.90 and CHF89.70 on the SIX exchange and comes after a year-to-date rise of 19.68%. Investors will watch margins, free cash flow dynamics and commentary on sterile-fill capacity. This piece uses market data, company metrics and Meyka AI analysis to set expectations for the upcoming SFZN.SW stock report and likely market reaction.

Earnings timing and what markets expect for SFZN.SW stock

Siegfried reports on 20 Feb 2026; the earnings announcement is the immediate catalyst for SFZN.SW stock. Analysts will focus on EBITDA margin, order book trends in sterile injectables, and commentary on commercial fill capacity. The company’s trailing EPS is 3.52 with a trailing PE of 25.40, so beats or misses could move the share price materially given current valuation.

Financial snapshot and valuation for SFZN.SW stock

Siegfried trades at CHF87.10 with a market cap of CHF3,912,883,338.00 and price averages of CHF82.73 (50-day) and CHF85.26 (200-day). Key ratios show a current ratio 2.91, debt/equity 0.45, and return on equity 15.38%, supporting balance-sheet resilience. Price-to-sales is 3.02 and price-to-book is 3.83, placing SFZN.SW stock slightly premium to typical Swiss healthcare peers.

Profitability, cash flow and risk signals for SFZN.SW stock

Margins are healthy: operating profit margin stands near 15.21% and net margin at 11.91%. Trailing operating cash flow per share is 4.47, but free cash flow per share is negative at -0.55, signaling elevated capex or working capital swings. Inventory days at 179.00 raise a working-capital flag that management must address in the earnings call.

Technical setup and intraday drivers for SFZN.SW stock

Technically SFZN.SW stock shows intraday weakness with RSI 48.33 and MACD histogram negative at -1.28, while ADX at 40.32 signals a strong trend. Bollinger bands place a middle band at CHF93.22 and a lower band at CHF84.40, so current price sits near the lower band. Volume today is 67,669 versus average 123,257, suggesting the move is active but not panicked.

Meyka AI grade and analyst framing for SFZN.SW stock

Meyka AI rates SFZN.SW with a score of 75.11 out of 100 (Grade B+ | BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Note other providers show a company rating of B (Neutral) dated 16 Feb 2026, reflecting mixed signals from valuation and balance-sheet strength. Grades are informational and not financial advice.

Final Thoughts

Earnings next week (20 Feb 2026) is the defining event for SFZN.SW stock. At CHF87.10 the market already prices a modest premium given a trailing PE of 25.40 and ROE of 15.38%. Meyka AI’s forecast model projects a 12‑month central target of CHF104.00, implying an upside of 16.37% versus the current price. Conservatively, a near-term price target of CHF92.00 (upside 5.64%) assumes a modest beat and stable margins; a downside scenario target of CHF78.00 (downside -10.42%) assumes revenue softness or working-capital pressure. Investors should watch free cash flow, inventory trends and management’s capacity commentary. Forecasts are model-based projections and not guarantees. For live updates and the full dataset visit the company site Siegfried and our SFZN.SW page on Meyka AI for real-time coverage and alerts.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.